Imaging biomarkers serve as important end points for clinical trials in the approval process for therapeutic drugs. Various criteria have been developed for objective interpretation of imaging studies.
Imaging Biomarkers in Clinical Trials
Apr 24th, 2014Apr 25th, 2014
Latest in Home
3D MRI technique helps plan treatment for pediatric heart conditions
February 12, 2026
Could AI scoring help with managing DCIS?
February 11, 2026














